Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats

Critical Care Medicine

Volumn 30, Issue 1, 2002, Pages 161-164

  Asakura, Hidesaku ^a   Suga, Yukio ^a   Aoshima, Keiji ^a   Ontachi, Yasuo ^a   Mizutani, Tomoe ^a   Kato, Minori ^a   Saito, Masanori ^a   Morishita, Eriko ^a   Yamazaki, Masahide ^a   Takami, Akiyoshi ^a   Miyamoto, Ken Ichi ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Animal model; Disseminated intravascular coagulation; Lipopolysaccharide; Tissue factor

Indexed keywords

ANTITHROMBIN III; D DIMER; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; EXPERIMENTAL MODEL; FIBRIN DEPOSITION; HEMOSTASIS; KIDNEY FAILURE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; UNIVERSITY HOSPITAL;

EID: 0036155208     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200201000-00023     Document Type: Article

References (24)

1. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders
2. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers
3. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation
4. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies measurement of plasma extrinsic pathway inhibitor activity
5. Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor
6. Lepirudin blunts endotoxin-induced coagulation activation
7. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
8. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades
9. Disseminated intravascular coagulation
10. Activation of coagulation after administration of tumor necrosis factor to normal subjects
11. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
12. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia
13. Immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states
14. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay
15. The prothrombin consumption time test
16. Evaluation of ready-to-use, liquid type reagents for creatinine assay "L-type Wako Creatinine F"
17. Optimization of methods for aspartate aminotransferase and alanine aminotransferase
18. Disseminated intravascular coagulation (DIC). Immunohistochemical study of fibrin-related materials (FRMs) in renal tissues
19. Effect of the administration of recombinant hirudin and/or tissue- plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits
20. Endotoxin-induced intravascular coagulation in rabbits: Effect of tissue plasminogen activator vs. urokinase of PAI generation, fibrin deposits and mortality
21. Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator
22. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
23. Disseminated intravascular coagulation: Findings in 346 patients
24. Disseminated intravascular coagulation. Clinical and pathophysiological mechanisms and manifestations